Coherus BioSciences And Other Big Stocks Moving Higher In Wednesday’s Pre-Market Session - Altimmune (NAS

U.S. stock futures were slightly lower this morning, with the Dow Jones futures falling around 5 points on Wednesday.

Shares of Coherus BioSciences, Inc. (NASDAQ:CHRS) shares rose sharply in pre-market trading following the company's announcement of the U.S. Food and Drug Administration's (FDA) approval of UDENYCA ONBODY for pegfilgrastim-cbqv.

UDENYCA ONBODY is the company's on-body injector presentation of UDENYCA (pegfilgrastim-cbqv), a pegfilgrastim biosimilar administered the day after chemotherapy to reduce the incidence of infection as manifested by febrile neutropenia.

Coherus BioSciences shares jumped 34.8% to $2.94 in pre-market trading.

Here are some big stocks recording gains in today’s pre-market trading session.

Burford Capital Limited (NYSE:BUR) rose 9.2% to $14.75 in pre-market trading.
TeraWulf Inc. (NASDAQ:WULF) shares gained 8.1% to $2.40 in pre-market trading after gaining 3% on Tuesday.
Bitfarms Ltd. (NASDAQ:BITF) shares climbed 8.1% to $3.50 in pre-market trading after gaining 8% on Tuesday.
Bit Digital, Inc. (NASDAQ:BTBT) shares gained 8.1% to $4.54 in pre-market trading. Bit Digital announced doubling size of fleet in its Bitcoin mining operations, to approximately 6.0 EH/s, during 2024.
HIVE Digital Technologies Ltd. (NASDAQ:HIVE) shares rose 7.2% to $5.49 in pre-market trading.
Cipher Mining Inc. (NASDAQ:CIFR) shares rose 6.2% to $5.29 in pre-market trading after gaining over 23% on Tuesday.
Altimmune, Inc. (NASDAQ:ALT) shares rose 4.1% to $11.42 in pre-market trading after gaining 18% on Tuesday.